Aspirin exacerbated respiratory disease (AERD): molecular and cellular diagnostic & prognostic approaches.
Habib HaybarNajmaldin SakiMohsen MalekniaMana MoghaddasiArmin BordbarMaliheh NaghaviPublished in: Molecular biology reports (2021)
Aspirin-exacerbated respiratory disease (AERD) is characterized by immune cells dysfunction. This study aimed to investigate the molecular mechanisms involved in AERD pathogenesis. Relevant literatures were identified by a PubMed search (2005-2019) of english language papers using the terms "Aspirin-exacerbated respiratory disease", "Allergic inflammation", "molecular mechanism" and "mutation". According to the significant role of inflammation in AERD development, ILC-2 is known as the most important cell in disease progression. ILC-2 produces cytokines that induce allergic reactions and also cause lipid mediators production, which activates mast cells and basophils, ultimately. Finally, Monoclonal antibody and Aspirin desensitization in patients can be a useful treatment strategy for prevention and treatment.
Keyphrases
- low dose
- cardiovascular events
- oxidative stress
- monoclonal antibody
- antiplatelet therapy
- end stage renal disease
- chronic kidney disease
- ejection fraction
- newly diagnosed
- single cell
- stem cells
- anti inflammatory drugs
- percutaneous coronary intervention
- acute coronary syndrome
- combination therapy
- allergic rhinitis
- atopic dermatitis
- patient reported